# GL Capital and Zylox-Tonbridge to invest $189m in LifeTech Scientific

Zylox-Tonbridge Medical Technology and GL Capital will jointly invest approximately HK$1.48bn ($189m) in LifeTech Scientific via GL Lighthouse Two Investment, which will subscribe for shares representing 16.7% of LifeTech's share capital. Zylox-Tonbridge also seeks a potential merger.

- Type: Investment
- Announced: 2026-11-09
- Where: China
- Value: $189.0M (1.48B HKD)
- Status: announced
- Products: peripheral vascular devices, neurovascular devices, aortic devices, structural heart devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeTech Scientific](https://endata.com/companies/38475.md) (partner)
- [Zylox-Tonbridge Medical Technology](https://endata.com/companies/94974.md) (investor)
- [GL Capital](https://endata.com/companies/94975.md) (investor)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/gl-capital-zylox-invest-189m-lifetech/), 2026-11-09: "Zylox-Tonbridge Medical Technology and GL Capital will jointly invest approximately HK$1.48bn ($189m) in LifeTech Scientific, with the former also seeking a potential merger between the two medical device manufacturers."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.